Sodium hyaluronate 0.25% used as a vehicle increases the bioavailability of topically administered gentamicin
- 1 March 1993
- journal article
- research article
- Published by Springer Nature in Albrecht von Graefes Archiv für Ophthalmologie
- Vol. 231 (3) , 157-161
- https://doi.org/10.1007/bf00920939
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Sodium hyaluronate as a carrier for intravitreal gentamicin an experimental studyActa Ophthalmologica, 1991
- Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphyEye, 1990
- Gelrite®: A novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timololInternational Journal of Pharmaceutics, 1989
- Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acidInternational Journal of Pharmaceutics, 1989
- Design and evaluation of controlled release systems for the eyeJournal of Controlled Release, 1987
- Polymer effects on ocular bioavailability—the influence of different liquid vehicles on the mydriatic response of tropicamide in humans and in rabbitsInternational Journal of Pharmaceutics, 1984
- Lacrimal scintigraphy. I. Compartmental analysis of data.British Journal of Ophthalmology, 1983
- TEAR FLOW IN NORMAL HUMAN EYES. DETERMINATION BY MEANS OF RADIOISOTOPE AND GAMMA CAMERAActa Ophthalmologica, 1979
- Recent Microbiological Studies with GentamicinThe Journal of Infectious Diseases, 1969
- Rheology of hyaluronic acidBiopolymers, 1968